Fore Biotherapeutics Investors

15 investors on Angel Roster list Fore Biotherapeutics in their portfolio. Most are private equity firms and venture capital firms, the most common stage is Series A and the largest groups are based in the United States, Israel and the United Kingdom.

Investors are matched on the company name in their portfolio, so companies that share the name Fore Biotherapeutics can appear together.

Investors listed
15
With verified email
53%
Most common stage
Series A
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 15 Fore Biotherapeutics investors

The most complete profiles first. Showing 15 of 15.

  • David BonitaVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 93 more

    Verified email available

  • Geoffrey HsuVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Adam FineVerified

    Venture Capital · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: ClarVista Medical, Cureatr, andros, Cartiva and 21 more

    Verified email available

  • Jonathan SilversteinVerified

    Private Equity Firm · United States

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Jonathan WangVerified

    Private Equity Firm · China

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Matthew FoyVerified

    Corporate Venture Capital · United Kingdom

    Health CareWomen FoundedLife ScienceBiotechnology

    Portfolio: Semprus BioSciences, Pulmocide, Syntaxin, CRISPR Therapeutics and 50 more

    Verified email available

  • Matthew WhitmanVerified

    Venture Capital · United States

    Health CareHospitalsGeneticsWomen Founded

    Portfolio: ClarVista Medical, Cureatr, andros, Cartiva and 21 more

    Verified email available

  • Rishi GuptaVerified

    Private Equity Firm · United States

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Verified email available

  • Carter Neild

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Chau Khuong

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Gennao Bio, Yisheng Biopharma and 89 more

    Contact details available

  • Ran Nussbaum

    Venture Capital, Founder, Private Equity Firm · Israel

    Series BHealth CareLife ScienceInformation Technology (IT)Manufacturing

    Portfolio: Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb and 48 more

    Contact details available

  • Scotland Stevens

    Venture Capital, Private Equity Firm, Investor · United States

    SeedSeries AHealth CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • ohad hammer

    Venture Capital, Scout, Private Equity Firm · Israel

    Series BHealth CareLife ScienceInformation Technology (IT)Manufacturing

    Portfolio: Rewalk Robotics, VBI Vaccines, CathWorks, ProtAb and 48 more

    Contact details available

  • Anat Naschitz

    Private Equity Firm · Israel

    Health CareLife ScienceInformation Technology (IT)Mobile

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

  • Erez Chimovits

    Private Equity Firm · Israel

    Health CareInvestment ManagementLife ScienceInformation Technology (IT)

    Portfolio: Edgewise Therapeutics, Syros Pharmaceuticals, Yisheng Biopharma, Evox Therapeutics and 87 more

    Contact details available

By investment stage

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many Fore Biotherapeutics investors are on Angel Roster?

Angel Roster lists 15 Fore Biotherapeutics investors. 8 of them (53%) include a verified email address.

What types of investors are they?

The most common investor types are Private Equity Firms (12), Venture Capital Firms (9) and Founder-Investors (1). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Fore Biotherapeutics investors invest in?

Among those that list a stage, the most common are Series A (5), Seed (5) and Series B (2).

Where are Fore Biotherapeutics investors based?

Most are based in the United States (9), Israel (4) and the United Kingdom (1).

Which companies have Fore Biotherapeutics investors backed?

The most-backed portfolio companies among them are Keros Therapeutics (12), Alizé Pharma (12), Silverback Therapeutics (12), Adicet Bio (12) and Delfi Diagnostics (12).

How do I contact Fore Biotherapeutics investors?

Create a free Angel Roster account to search and filter all 15, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.